• 1. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 2. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 3. Alternative donor substrates for inverting and retaining glycosyltransferases?
  Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367
• 4. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 5. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Carboxylic acid derivatives Carboxylic acid amides

Introduction to 4-amino-1-ethyl-N-propyl-1H-pyrazole-3-carboxamide (CAS No. 1001500-16-8)

4-amino-1-ethyl-N-propyl-1H-pyrazole-3-carboxamide, identified by the Chemical Abstracts Service Number (CAS No.) 1001500-16-8, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the pyrazole class, a scaffold widely recognized for its diverse biological activities and utility in drug development. The structural features of 4-amino-1-ethyl-N-propyl-1H-pyrazole-3-carboxamide, particularly its amino, ethyl, and propyl substituents, contribute to its unique chemical properties and potential pharmacological effects.

The pyrazole core is a prominent motif in medicinal chemistry, exhibiting a broad spectrum of biological activities ranging from antimicrobial and anti-inflammatory to anticancer and antiviral properties. The presence of an amino group at the 4-position and ethyl and propyl groups at the 1- and 3-positions, respectively, enhances the compound's interactability with biological targets. This structural configuration makes 4-amino-1-ethyl-N-propyl-1H-pyrazole-3-carboxamide a promising candidate for further investigation in drug discovery.

In recent years, there has been a surge in research focused on developing novel heterocyclic compounds with enhanced pharmacological profiles. Pyrazole derivatives have been extensively studied due to their favorable pharmacokinetic properties and low toxicity. The compound 4-amino-1-ethyl-N-propyl-1H-pyrazole-3-carboxamide has been explored in various preclinical studies for its potential therapeutic applications. Its ability to modulate multiple biological pathways suggests that it may serve as a versatile lead compound for the development of new drugs.

One of the most compelling aspects of 4-amino-1-ethyl-N-propyl-1H-pyrazole-3-carboxamide is its potential as an intermediate in the synthesis of more complex pharmaceutical agents. The pyrazole ring can be further functionalized to introduce additional pharmacophores, thereby expanding its therapeutic potential. Researchers have leveraged this flexibility to design derivatives with improved efficacy and selectivity against specific disease targets.

The synthesis of 4-amino-1-ethyl-N-propyl-1H-pyrazole-3-carboxamide involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Advanced synthetic methodologies, such as catalytic hydrogenation and nucleophilic substitution, have been employed to construct the desired molecular framework efficiently. These synthetic strategies not only highlight the compound's synthetic accessibility but also underscore the importance of robust chemical techniques in medicinal chemistry.

Recent studies have demonstrated that 4-amino-1-ethyl-N-propyl-1H-pyrazole-3-carboxamide exhibits notable inhibitory activity against certain enzymes implicated in inflammatory diseases. By targeting these enzymes, the compound has shown promise in reducing inflammation and alleviating symptoms associated with chronic conditions such as rheumatoid arthritis. Additionally, preliminary data suggest that it may have neuroprotective effects, making it a candidate for investigating potential treatments for neurodegenerative disorders like Alzheimer's disease.

The pharmacokinetic profile of 4-amino-1-ethyl-N-propyl-1H-pyrazole-3-carboxamide has been carefully evaluated through in vitro and in vivo studies. These investigations have revealed that the compound exhibits favorable absorption, distribution, metabolism, and excretion (ADME) properties, which are critical factors for determining its clinical viability. The bioavailability and metabolic stability observed suggest that it could be developed into a viable therapeutic agent with reasonable dosing regimens.

In conclusion, 4-amino-1-ethyl-N-propyl-1H-pyrazole-3-carboxamide (CAS No. 1001500-16-8) represents a significant advancement in pharmaceutical research due to its versatile biological activities and synthetic feasibility. Its potential applications in treating inflammatory and neurodegenerative diseases make it a valuable asset in the quest for novel therapeutic interventions. As research continues to uncover new insights into its mechanisms of action, this compound is poised to play a pivotal role in shaping future drug development strategies.

• 1467425-46-2(4-amino-N,N,1-triethyl-1H-pyrazole-3-carboxamide)
• 1491506-27-4(4-amino-N,1-diethyl-N-methyl-1H-pyrazole-3-carboxamide)
• 1004194-71-1(4-Amino-1-ethyl-1H-pyrazole-3-carboxylic acid isobutyl-amide)
• 895930-41-3(4-amino-N-cyclopentyl-1-ethyl-1H-pyrazole-3-carboxamide)
• 1001500-46-4(4-Amino-1-ethyl-1 H -pyrazole-3-carboxylic acid methylamide)
• 1185005-86-0(4-Amino-1-ethyl-1 H -pyrazole-3-carboxylic acid propylamide; hydrochloride)
• 1431963-40-4(4-Amino-1-ethyl-N-(3-pyrazol-1-ylpropyl)pyrazole-3-carboxamide;hydrochloride)
• 1006485-32-0(4-amino-N,1-diethyl-1H-pyrazole-3-carboxamide)
• 1004644-20-5(4-Amino-1-ethyl-1H-pyrazole-3-carboxylic acid isopropylamide)
• 1005583-98-1(1-Ethyl-4-formylamino-1H-pyrazole-3-carboxylic acid propylamide)